Almac Group, inVentiv Health partner
Almac Clinical Technologies, part of the Almac Group, a privately held contract pharmaceutical development and manufacturing organization, has announced the formation of a strategic partnership with inVentiv Health, a biopharma outsourcing company combining a leading CRO and the industry’s only contract commercial organization (CCO). The partnership presents an opportunity for both organizations to provide clients and sites with streamlined access to best-in-class clinical trial Interactive Response Technology (IRT) solutions.
Through the strategic partnership, Almac Clinical Technologies will now provide IRT solutions to inVentiv clients, including its market-leading IXRS technology. This technology has been used in over 2,000 trials and provides sponsors with the visibility and control needed to make data-driven decisions. inVentiv Health’s IRT specialists will also join Almac Clinical Technologies’ 500+ person expert consultancy team. This team and technology transition will allow Almac and inVentiv to seamlessly service current inVentiv Health IRT clients.
Gregory Skalicky, chief commercial officer, inVentiv Health Clinical Division, said, “We’re committed to accelerating clinical trials and see tremendous value in applying leading technology solutions to streamline the process. This partnership will enable inVentiv Health to enhance its clinical services continuum by offering clients access to Almac’s comprehensive, best-in-class IRT services to unlock further efficiencies in trial study configuration and deployment.”